Immunoglobulin replacement in chronic lymphocytic leukaemia.
Infection is a frequent cause of morbidity and mortality in patients with chronic lymphocytic leukaemia (CLL) and low-grade B cell lymphomas. Several factors may contribute to an increased risk of infection in individual patients but, overall, impaired antibody production--commonly manifest as hypogammaglobulinaemia--appears to be a major factor. Early studies of immunoglobulin replacement using the intramuscular route showed equivocal results. More recently, highly purified preparations of I...Expand abstract
- Nouvelle revue francaise d'hematologie
- Publication date:
- Source identifiers:
- Copyright date:
If you are the owner of this record, you can report an update to it here: Report update to this record